Edinburgh Investment Trust’s half-year: rising NAV, bigger dividend, tighter discount
Edinburgh Investment Trust has posted a steady first half to 30 September 2025. Net asset value (NAV) total return was 7.9% and the share price total return was 10.2%, helped by a narrower discount. The FTSE All-Share did 11.6%, so there was some short-term underperformance, but the long-run record since Liontrust took over in March 2020 remains ahead of the index.
The Board has declared a first interim dividend of 7.6p per share, up 10.1% year-on-year, and is guiding to 32.0p for the full year, implying a 4.0% yield at the time of writing.
Key numbers investors should know
| Metric | 30 Sep 2025 | 31 Mar 2025 | Movement |
|---|---|---|---|
| NAV total return (six months) | 7.9% | – | – |
| Share price total return (six months) | 10.2% | – | – |
| FTSE All-Share total return (six months) | 11.6% | – | – |
| NAV per share – debt at fair value | 866.23p | 817.16p | +6.0% |
| Share price | 800.00p | 740.00p | +8.1% |
| Discount to NAV | (7.6)% | (9.4)% | Narrowed |
| Revenue return per share (H1) | 13.96p | 13.08p | +6.7% |
| First interim dividend | 7.60p | 6.90p | +10.1% |
| Full-year dividend guidance | 32.0p | – | Board expectation |
| Net assets | £1,162.7 million | £1,125.9 million | +£36.8 million |
| Net gearing (debt at fair value) | 5.1% | 5.0% | +0.1 ppt |
| Debt | £120 million fixed at 2.4% | £120 million | 22 years to run |
Quick jargon buster: NAV is the per-share value of the portfolio after all liabilities; the discount is how far the share price sits below NAV; gearing is borrowing used to boost equity exposure.
Performance: why the trust lagged the index this half
Edinburgh’s 7.9% NAV total return was respectable, but shy of the FTSE All-Share’s 11.6%. The portfolio managers put that down to two things. First, not owning Rolls-Royce, which surged again on strong execution, hurt on a relative basis. Second, Haleon – a large holding – was weak amid softer US demand, an inventory overhang and pressure in vitamins and smokers’ health. The team added to Haleon on the dip, signalling conviction.
There were bright spots. Retail and consumer holdings did the heavy lifting, notably Tesco (gaining share), Whitbread (self-help to improve returns), and Dunelm.
Portfolio moves: adding on weakness and two new names
The trust remains concentrated yet diversified with 44 holdings and just 5.5% in non-UK stocks. Activity was classic “buy the wobble”. Edinburgh added to Haleon and London Stock Exchange Group (LSEG) after a soft patch in subscriptions and market chatter about AI disruption. Management argues LSEG’s data moat should let it harness AI rather than be hurt by it.
New positions were opened in Marshalls (building products) and Trainline (capital-light ticketing platform). Funding came mainly from trimming Tesco, Sainsbury and Shell; the BAE Systems position was sold into strength; and US-listed Verisk was reduced.
Top 10 holdings at period-end
- Shell – 5.7%
- Unilever – 5.6%
- Haleon – 5.0%
- GSK – 4.8%
- Dunelm – 4.4%
- NatWest – 4.4%
- National Grid – 4.0%
- Compass – 3.9%
- AstraZeneca – 3.7%
- Whitbread – 3.4%
The team frames exposure across seven economic themes, including Market Champions (20%), Self-Help (17%), Data and Analytics (15%), Capital Optimisation (14% and 9% stated), Innovation (12%) and Decarbonisation (11%).
Dividend: up 10.1% now, 32.0p targeted for the year
The first interim dividend of 7.6p is a 10.1% lift on last year’s comparable payment. The Board expects to pay 32.0p for the full year, “assuming no material change in market conditions and/or income levels”, equating to a 4.0% yield at the time of writing. Importantly, they want dividend growth to exceed UK inflation over time.
On coverage, first-half income per share was 14.0p, with the Board noting dividends of 15.2p for the period – a modest uncovered position. That shortfall is comfortably funded from the revenue reserve and, where appropriate, capital. The Chair also flagged that company share buybacks across the UK market are rising, which support shareholder returns but don’t count as accounting income – another reason the trust blends income and capital to fund dividends.
A tweak is proposed to smooth the payment schedule: moving to four equally spaced interim dividends from 2026/27.
Discount and buybacks: quiet progress
Edinburgh’s discount narrowed from 9.4% to 7.6% over the six months, helping the share price total return outrun the NAV. The company repurchased 2.6% of its shares in the period to manage the discount and enhance NAV for remaining holders. After the period end, a further 3,000,500 shares were bought back at an average 815.16p.
Balance sheet and gearing: long, cheap debt locked in
The trust’s £120 million of unsecured loan notes are fixed at 2.4% with 22 years to run – enviably priced in today’s world. Net gearing was 5.1% at fair value, up marginally from 5.0%. With markets rising, that gearing helped. NAV per share was 866.23p on a debt-at-fair-value basis, or 827.48p on debt at par.
Outlook: cautious on the economy, constructive on UK equities
The managers are “cautiously optimistic” on the UK. Inflation sits at 3.8% and is expected to fall, which would give the Bank of England scope to cut rates. UK market valuations still look appealing and a large share of FTSE earnings are earned overseas, reducing reliance on UK domestic growth.
The risks aren’t trivial: geopolitics, global debt levels, and the usual pre-Budget unknowns. The trust’s response remains bottom-up stock picking across quality businesses at attractive prices.
My take: the trade-offs are clear
- Positives: 10.1% dividend rise with a clear path to 32.0p this year; discount narrowing; a very low-cost, long-dated debt structure; ongoing buybacks; and a five-and-a-half-year NAV total return since March 2020 of 15.4% p.a. versus 13.1% for the FTSE All-Share.
- Negatives: short-term underperformance versus the benchmark; a modestly uncovered dividend in H1; and a relative underweight in banks during a period when the sector rallied hard.
Overall, this is a solid half-year. If you want a UK equity trust aiming to blend income growth with capital gains, an active approach to discount control, and a management team willing to add on weakness, Edinburgh remains in the conversation. The key watch items into year-end are Haleon’s recovery, LSEG execution, and whether the discount keeps tightening.
